0.0287
+0.0071
+(32.87%)
At close: January 10 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-6,906.5290
-7,239.5140
-3,875.8110
-4,489.4400
-3,136.1220
Investing Cash Flow
-100.0000
--
--
-1,750.0000
--
Financing Cash Flow
6,732.4710
4,917.3460
5,487.5550
8,216.0330
2,898.9990
End Cash Position
1,137.4530
1,469.1340
3,791.3020
2,179.5580
202.9650
Capital Expenditure
--
--
--
-1,750.0000
--
Issuance of Capital Stock
4,969.9720
5,292.3460
3,271.4860
10,136.5000
1,067.4990
Issuance of Debt
2,000.0000
650.0000
--
77.5950
2,081.5000
Repayment of Debt
-937.5010
-1,225.0000
-2,417.0000
-1,700.0000
-250.0000
Repurchase of Capital Stock
--
--
--
-247.1650
--
Free Cash Flow
-6,906.5290
-7,239.5140
-3,875.8110
-6,239.4400
-3,136.1220
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DOSEF Doseology Sciences Inc.
0.1405
0.00%
DRMAW Dermata Therapeutics, Inc.
0.0149
+34.23%
GSTC GlobeStar Therapeutics Corporation
0.0004
+16.67%
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
NLSPW NLS Pharmaceutics AG
0.0162
-6.36%
CDIOW Cardio Diagnostics Holdings, Inc.
0.0780
-2.26%
ENDV Endonovo Therapeutics, Inc.
0.0004
0.00%
JSPRW Jasper Therapeutics, Inc.
0.1600
+4.92%
NRX.V NurExone Biologic Inc.
0.6800
+4.62%